Cargando…
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
CheckMate 743 trial demonstrated survival benefit of immunotherapy in first line in MPM with some differences in the efficacy of chemotherapy according to histology. The objective of this study is to characterize the impact of chemotherapy according to histology in patients diagnosed with MPM at our...
Autores principales: | Cedres, Susana, Assaf, Juan-David, Iranzo, Patricia, Callejo, Ana, Pardo, Nuria, Navarro, Alejandro, Martinez-Marti, Alex, Marmolejo, David, Rezqallah, Alejandra, Carbonell, Caterina, Frigola, Joan, Amat, Ramon, Pedrola, Anna, Dienstmann, Rodrigo, Felip, Enriqueta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560806/ https://www.ncbi.nlm.nih.gov/pubmed/34725384 http://dx.doi.org/10.1038/s41598-021-00831-4 |
Ejemplares similares
-
MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
por: Cedres, S., et al.
Publicado: (2021) -
Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
por: Callejo, Ana, et al.
Publicado: (2021) -
Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
por: Cedres, Susana, et al.
Publicado: (2023) -
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
por: Iranzo, Patricia, et al.
Publicado: (2022) -
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
por: Frigola, Joan, et al.
Publicado: (2022)